| Value | ₹9.46 Cr |
|---|---|
| Execution period | Conversion within 18 months from allotment, lapsing by 15 May 2028 |
NSE filing, NSE: SATKARTAR. Summary written from the filing by ALFA Finder's alert engine.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹150.00
- Market cap
- ₹236.9 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 13.8×Sector 49.0×
- Promoter holding
- 63.49%
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life plans a 10-bed Ayurveda hospital in Bengaluru, its first South India facility. Estimated investment is ₹1.25 Crore, with operations targeted by March 2027.
- Value
- ₹1.25 Cr
- Execution
- OPD and therapy centre operations from December 2026; full hospital operations by March 2027, subject to approvals.
- hospital beds
- 10.0 beds
Sat Kartar Life Business Update
Sat Kartar Life received the Ayush Quality Mark Certification for its Sanjeevan unit. The certification recognises its quality standards and operational practices.
Sat Kartar Life Other Announcement
Sat Kartar Life intends to voluntarily submit quarterly financial results from the quarter ending December 31, 2026, in addition to half-yearly results. No financial figures are disclosed.
Sat Kartar Life Capacity Expansion: ₹0.75 Cr Investment
Sat Kartar Life proposes a new 15-bed Ayurveda hospital and wellness centre in Ludhiana, Punjab, with an estimated investment of ₹75 lakh. It is expected to be operational by March 2027, subject to approvals.
- Value
- ₹0.75 Cr
- Execution
- Expected to be operational by March 2027, subject to approvals and operational readiness
- hospital beds
- 15.0 beds
Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.
- Value
- ₹1.25 Cr
- Ayurveda hospital beds
- 30 beds
Sat Kartar Life Convertible Warrants
Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.
Other convertible warrants announcements
All →Kizi Apparels Convertible Warrants
Kizi Apparels corrected its EGM notice after BSE observations. Excluding allottee Anil Surana cuts the warrant issue to 50,55,000 warrants worth Rs8.85 Crore.
- Value
- ₹8.85 Cr
Sanjivani Paranteral Convertible Warrants
Sanjivani Paranteral allotted 5,00,000 convertible warrants to promoter Ashwani Khemka at Rs147.39 each. Aggregate issue Rs7.37 Crore; 25% upfront received, balance due within 18 months.
- Value
- ₹7.37 Cr
Simplex Infrastructures Convertible Warrants
Simplex Infrastructures allotted 26,30,104 equity shares on conversion of warrants, receiving Rs.57.01 Crore as the balance 75% consideration. Allottees include promoter group Ajay Merchants and three non-promoter investors.
- Value
- ₹57.01 Cr
Taylormade Renewables Convertible Warrants
Taylormade Renewables' EGM approved a special resolution to issue convertible warrants preferentially to promoters. The resolution passed, with 20,187 votes in favour and 1 against.
Simplex Castings Convertible Warrants
Ketan Moolchand Shah and promoter group disclosed 9,52,500 convertible warrants allotted on November 18, 2026. Preferential allotment lifts promoter diluted holding to 43.38 percent.
- Execution
- Warrants convertible into one fully paid-up equity share of Rs. 2/- each within 18 months of allotment
Emrock Corporation Convertible Warrants
Emrock Corp received BSE in-principle approval for preferential issue of 14,84,000 convertible warrants at Rs.290 minimum per share, worth ~Rs.43 Crore.
- Value
- ₹43.04 Cr